In the course of this dramatic pandemic, the role and significance of sex-and gender-based medicine has, in our opinion, become clear to all. Because the severity and death rate are higher in men than in women.
Covid-19 interacts with another pandemic: non-communicable diseases, in fact, the subjects affected by these diseases such as diabetes are those who have the most serious and lethal forms of Covid-19.
Non-communicable diseases aggregate with each other (for example diabetes mellitus and hypertension) and strongly depend on socio-economic inequalities indicating that Covid-19 is a syndemla. Therefore, it requires a very complex approach that goes beyond the concept of treating the disease to get to take care of people.
Governments of G20, therefore, should stop considering disease only as a purely biological fact because it also depends on social determinants (economic status, education, loneliness, religion, geographical location) because only by integrating and aggregating the social determinants of health and biological facts it is possible to plan how to reduce and mitigate disparities in health.
There is a newly born dimension of medicine: sex-based and gender-based medicine better known as gender medicine that considers both biomedicine-derived and personal care.
Therefore, G20 member states should implement gender medicine through a globally funded global plan to ensure the health of the individual and the population because health is affected by factors that reside outside the health systems.
7 May 2021
Gender equity in health: a long journey
25 April 2021
Equity in health
Members of the Commission
W20 Coordinator Equity in Health Commission
W20 Facilitator Equity in Health Commission and Presidente FEMTEC
Department of Biomedical Sciences, Section of Neurosciences and Clinical Pharmacology, University of Cagliari, Italy
PhD in Gender Pharmacology from the University of Sassari
Director of Center for Gender-specific medicine. Italian National Institute of Health
PhD Med, PhD Pharm, MBA. Professor of Kidney Epidemiology. Karolinska Institutet
Department of Clinical and Experimental Medicine, University of Pisa
Tel Aviv University and Rabin Medical Center
Medical University of Vienna, Austria
Ph.D. Professor, Department of Molecular Microbiology and Immunology, Co-director
Director General, European Institute of Women's Health,clg
Scientific Director, Istituto Clinico Humanitas, Emeritus Professor, Humanitas University
Full professor of Cardiology, Dep of Clinical Sciences and Public Health, University of Cagliari, Sardinia, Italy
MD, PhD, Assistant Professor of Internal Medicine (RTDb), Department of Translational Medicine, Ferrara, Italy
Gender in Medicine, Charité, Berlin, Universität Zürich
MD, Scientific Director, Institute of Gender and Health, Canadian Institutes of Health Research, Canada
Director of Clinical Governance, Bupa ANZ. Chair of the Board of Dental Health Services Victoria
Associate professor of Gender Medicine at Maastricht University
Aidda is the official host organization of W20
Via degli Scialoja 18, 00196 Roma
Tel. 06 3230578 / Fax. 06 3230562